The complement system is a central component of host defense but can also contribute to the inflammation seen in pathological conditions. The C1s protease of the first complement component, the C1 complex, initiates the pathway. In this study we have elucidated the full specificity of the enzyme for the first time using a randomized phage display library. It was found that, aside from the crucial P 1 position, the S 3 and S 2 subsites (in that order) played the greatest role in determining specificity. C1s prefers Leu or Val at P 3 and Gly or Ala residues at P 2 . Apart from the S 2 position, which showed specificity for Leu, prime subsites did not greatly affect specificity. It was evident, however, that together they significantly contributed to the efficiency of cleavage of a peptide. A peptide substrate based on the top sequence obtained in the phage display validated these results and produced the best kinetics of any C1s substrate to date. The results allow an understanding of the active site specificity of the C1s protease for the first time and provide a basis for the development of specific inhibitors aimed at controlling inflammation associated with complement activation in adverse pathological situations.
Complement is an integral component of the adaptive and innate immune systems and represents one of the major effector systems for the immune response (1). However, inadvertent or unwanted complement activation can be harmful to the body (2) ; an example of this is the activation of the system during reperfusion injury after myocardial infarction (3) . Thus, the control of complement may also have an important bearing on preventing or attenuating certain inflammatory diseases. The complement system consists of a highly regulated cascade of proteolytic enzymes and other proteins (1) , and it is suggested that control of the system could be achieved through the use of highly targeted inhibitors of the serine proteases (2) . In particular, the initiating proteases of the C1 complex of the classical pathway are of great relevance to such an approach since control of cascade systems is logically most efficiently achieved by shutting off the initiation steps.
The C1 component is a complex of the binding protein C1q and two proenzymes, C1r and C1s (4) . Upon binding of IgG to the heads of C1q, C1r undergoes autoactivation to cleave and activate C1s. C1s appears to be a highly specific protease, cleaving the C4 and C2 components to instigate a sequence of activation steps of other components of the complement system, culminating in the formation of the membrane attack complex, which induces cell lysis (5, 6) . The only other protein known to interact with C1s physiologically is the serpin, C1 inhibitor, which inhibits and, thus, controls the enzyme. Several studies have revealed that C1s is able to cleave substrates outside complement (7) (8) (9) (10) (11) , but the physiological relevance of these interactions remains to be understood.
Understanding the substrate specificity of an enzyme is a prerequisite for the development of specific inhibitors and also allows insights into overall function. C1s is interesting in that it apparently only interacts with its major substrates (C2 and C4) and C1-inhibitor, which suggests that it is highly restricted in terms of its substrate specificity. Analysis of the crystal structure of the catalytic domain (CCP2-SP) of C1s demonstrated restricted access to subsidiary binding sites in the active site of the SP domain (12), with two major insertions around the non-prime binding subsites 3 being a predominant feature. These structural data suggest that the non-prime region may play a crucial role in governing C1s specificity.
The activity of C1s against synthetic peptide substrates covering the non-prime side of substrates has been mapped to a limited extent, indicating that the enzyme is quite specific in this region (13) (14) (15) . The use of substrates based on the cleavage sequences of C4 and C2, the physiological substrates of human C1s, to investigate the kinetic parameters of the interaction of these substrates with the active site of the enzyme has previously been reported (14) . These studies demonstrated a dramatic increase in the affinity of C1s for substrates that contained prime side residues. However, a complete study of the specificity determinants of the enzyme has not been conducted, and the role of the non-prime side residues has not been fully investigated. Here, we employed a phage display library to determine the full specificity of the C1s protease. Our data reveal the first complete picture of C1s specificity, providing insights into this important enzymes selectivity for protein substrates.
EXPERIMENTAL PROCEDURES
Materials-Fluorescent-quenched substrates (C2 P 4 -P 4 Ј substrate (2Abz 4 -SLGRKIQI-Lys(Dnp)-NH 2 2 ), C4 P 4 -P 4 Ј substrate (2Abz-GLQRALEI-Lys(Dnp)-NH 2 ), C1-inhibitor P 4 -P 4 Ј substrate (2Abz-SVARTLLV-Lys(Dnp)-NH 2 ), and the peptide from phage display (2Abz-GYLGRSYKVG-Lys(Dnp)D-OH)) were synthesized at greater than 80% purity by Auspep (Melbourne, Vic., Australia). Metal-chelating Sepharose beads were purchased from Amersham Biosciences. Commercial PCR clean-up kits were purchased from Millipore (Bil-lerica, MA). The PCR primers were generic primers based on the Novagen T7SelectUP and DOWN primers. BIG-DYE Version 3.1 was purchased from the Monash University Micromon DNA sequencing facility. Human C1s (activated two chain) was purchased from Calbiochem (San Diego, CA) and made up to 1 mg/ml using sterile laboratory grade water.
Assay of Cleavage of Peptide Substrates-Assays were carried out in fluorescent assay buffer (0.05 M Tris, 0.15 M NaCl, 0.2% (w/v) polyethylene glycol 8000, 0.02% (w/v) sodium azide) at 37°C using final substrate concentrations in the range from 0.5 to 20 M substrate. Generally, C1s was used at a concentration of 2.5 g/ml. The rate of increase of fluorescence for the assays was measured on a BMG Technologies FluoStar Galaxy fluorescent plate reader using an excitation wavelength of 320 nm and an emission wavelength of 420 nm. The initial reaction rate was estimated at a single concentration of enzyme from duplicate measurements over a range of substrate concentrations. To determine steady-state reaction constants (V max , K 0.5 , and h (Hill coefficient)), the experimental results were fitted using the GraphPad Prism Version 3.0 computer program to an equation describing positive cooperativity
, which defines the relationship between reaction rate and substrate concentration when more than one binding site applies (as described in O'Brien et al. (14) ). The k cat values were calculated as described previously (14) .
Phage Display-The T7Select1-1b Phage Display system (Novagen) was used to generate a randomized protease substrate library 5 following the approach of Cwirla et al. (16) . The library was generated by synthesizing a degenerate oligonucleotide, annealing it to two complementary half-site oligonucleotides, ligating the resulting heteroduplex to T7Select1-1b vector arms, and adding to a T7 phage packaging extract. The degenerate oligonucleotides had the following sequence: 5Ј-AAT-TCTCTCACTCCAGGCGGC(NNK) 4 CGY(NNK) 4 CATCACCATC-ACCATCACA-3Ј (where N represents any nucleotide and K represents T/C). The half-site oligonucleotides were 5Ј-GCCGCCTGGAGTGA-GAG-3Ј and 5Ј-AGCTTACTGATGCTGATGCTGATG-3Ј. This adds a randomized octameric peptide, interrupted by a central arginine, and a hexahistidine tag to the C terminus of the 10B coat protein. The titer of this fixed arginine library was 8.1 ϫ 10 5 plaque-forming units. This was amplified to yield a library of 2.8 ϫ 10 10 plaque-forming units. About 10 9 plaque-forming units of amplified phage in phage extraction buffer were bound to nickel-chelated Sepharose beads at 4°C. Unbound phage were removed by washing the beads with phage wash buffer (850 mM NaCl, 0.1% (v/v) Tween 20 in phosphate-buffered saline). After 2 washes in 1 mM MgSO 4 in phosphate-buffered saline, the bead/phage suspension was divided into two 500-l aliquots in the same buffer (control and treatment). The phage selection commenced by the addition of 200 nM C1s protease to the treatment tube. Both the treated and control beads were incubated overnight at 37°C. Cleaved phage were recovered from the supernatant, titrated, and amplified to form the sublibrary for the next round of selection. Phage that remained bound to the beads were eluted with 0.5 M imidazole and titrated to assess cleavage efficiency. After the indicated rounds, 96 individual phage plaques were randomly selected for sequencing. The phage DNA was amplified by PCR using the T7 SelectUP and DOWN primers (T7Select cloning kit, Novagen). Sequencing of PCR products employing the same primers was carried out using the Big Dye 3.1 kit (Amersham Biosciences).
Verification of C1s Protease Specificity in an Optimal Phage Display Peptide Library-An optimal phage display peptide library consisting of phage expressing eight known peptide sequences was constructed to form the starting library for a further phage selection experiment. The following peptide sequences were selected and combined in equal proportions to form the optimal library: FGGS-LKLS, TLQR-RSEQ, YVGR-LLRG, AMYR-VEWL, YLGR-SYKV, ALFR-APRA, SLIR-KARA, and YLGR-IGVY. The library was diluted so that it had a titer of ϳ10 9 phage/ml. Phage selection by protease digestion then commenced as described previously. In total, four rounds of selection were completed.
RESULTS AND DISCUSSION

Determination of C1s Substrate Recognition Profile by Phage
Selection-The C terminus of the T7 phage capsid protein was manipulated to contain a randomized peptide of nine amino acids, with the exception of a fixed arginine at the central (putative P 1 ) position. The P 5 position of the nonamer was considered to be a spacer in this study due to its close proximity to the T7 phage body. As a result, the data corresponding to the P 5 residues of the phage peptides were not analyzed. The nine-amino acid insert is followed by a hexahistidine tag, which serves to anchor the phage to a matrix, in this case nickel-chelating Sepharose beads. The C1s protease is able to cleave the peptides of susceptible phage, releasing the phage from the beads. The cleaved phage were subsequently collected and amplified. A control experiment in which no protease was added was used as a reference to determine the background level of phage dissociation from the matrix without protease treatment. After each round of protease digestion, a titration was performed to determine the number of released phage from each eluted sample for both the protease-treated and control experiments. The addition of C1s to amplified sub-libraries at selection rounds five and seven gave 12.8-and 14.5-fold greater release of phage than the control library, respectively, the highest obtained across the selection rounds carried out. 288 phage were selected for sequencing from selection rounds 5 and 7. Results from each round were very similar, and therefore, the sequences obtained from each round were considered in one analysis. In total, 219 readable sequences were obtained, comprising 93 different peptide sequences. The predominant phage peptide sequence was YLGRSYKV at 40% (Fig. 1) . A total of 33 peptide sequences occurred more than once, and 8 occurred at least 3 times.
Because the prevalence of the repeated phage peptides was likely to skew the amino acid trends at each position, the 93 different phage peptide sequences were analyzed (Fig. 2) . The sequences were aligned around the arginine at the putative P 1 due to its fixed position in this 5 A. Matthews and P. Bird, manuscript in preparation. library and the fact that C1s is known to only accept an arginine residue at the P 1 position of substrates (17) .
Leucine was found at P 3 with a frequency greater than that found for any amino acid at any position from P 4 -P 4 Ј, suggesting that S 3 is the most selective subsite in C1s (Fig. 2) . Glycine and valine also occurred at frequencies greater than 10% at this position. The S 2 subsite accepts small amino acids, with Gly and Ala being the most predominant amino acids found at the P 2 position (Fig. 2) . The frequency of occurrence of Gly at P 2 is second only to the frequency for Leu at P 3 across all of the results. Tyr, Ser, and Ala were the most preferred amino acids at the P 4 position (Fig. 2) .
In contrast to the strong amino acid preferences seen on the nonprime side of the cleavage site, the prime side shows less selectivity, with the exception of the P 2 Ј position where leucine was clearly most preferred residue and occurred with the third highest frequency of any amino acid at any position (Fig. 2) . Overall, at P 1 Ј hydrophobic amino acids (Leu, Val, Ala) were favored, but Ser was the most preferred residue. There was a preference for Arg, Val, Leu, and Gly residues at the P 3 Ј position, whereas the S 4 Ј subsite showed relatively little specificity but had preferences of Val Ͼ Leu ϭ Ala Ͼ Arg (Fig. 2) .
Ranking the C1s Phage Substrates-The simplest interpretation of the results shown in Fig. 1 is that the frequency at which a particular phage appears is directly proportional to the efficiency of its cleavage by C1s. Thus, YLGRSYKV would represent the best C1s substrate retrieved from the library. Alternatively, other factors, such as uneven amplification, may lead to over-representation of a particular phage in the selection process.
To distinguish between these possibilities, we constructed a second library consisting of a mixture of equal numbers of the six most frequently occurring sequences from the first library plus two sequences that were only represented once and, therefore, were considered to be controls to reflect more poorly selected sequences. Ninety-six individual phage plaques were sequenced from round three of selection, which had the highest -fold difference between control and treated phage samples, yielding a total of 94 readable sequences. The results of this experiment verified that YLGRSYKV was the best of the sequences (58% occurrence) followed by the YLGRIGVY peptide (17% occurrence), ALFRAPRA (14% occurrence), YVGRLLRG (6% occurrence), TLQRRSEQ (4% occurrence), and SLIRKARA (1% occurrence). The FGGSLKLS peptide, which did not contain the fixed arginine at P 1 , and AMYRVEWL were not observed, suggesting that they are not readily cleaved by the protease.
Validation of Phage Display Results Using a Synthetic Peptide Substrate-To confirm that the sequences obtained from the phage display analysis are optimal C1s substrates, a synthetic peptide substrate based on the YLGRSYKV sequence was synthesized commercially. The kinetic parameters for C1s-mediated cleavage of this peptide, 2Abz-GYLGRSYKVG-Lys(Dnp)D-OH, were determined in comparison to the physiological cleavage sequences, C2, C4, and C1-inhibitor. For all of the substrates analyzed, the dependence of the initial velocity on substrate concentration was best fitted to a sigmoidal curve fit, as found previously for the C2 and C4 substrates (14) . This analysis represents a simplistic analysis of potentially complex non-Michaelis-Menten behavior by the enzyme for which the physical basis is not completely understood at present. The values for k cat /K 0.5 for hydrolysis of the substrates shown in TABLE ONE allow us to simply rank the efficiency of cleavage of the phage substrate in relation to physiological cleavage sequences, however. The phage substrate showed a 4.7-fold higher k cat / K 0.5 value than the C2 substrate. The C4 and C1 inhibitor substrates had ϳ6-and 21-fold lower k cat /K 0.5 values, respectively, than the phagederived substrate.
Overall Evaluation of C1s Specificity in Relation to Physiological Cleavage Sequences-The results of this study strongly suggest that the non-prime side subsites of C1s are more selective than the prime side subsites. The S 3 position was easily the most selective of the seven positions, with a very strong preference for Leu and, to a lesser extent, Val and Gly residues (Fig. 2) . Leucine is found at both the C2 and C4 P 3 positions, whereas Val is found at this position in the C1 inhibitor cleavage sequence (TABLE ONE). The S 2 subsite was the next most selective, with a strong preference for Gly and, to a lesser extent, Ala, evident. These results gelled with physiological sequences where both Gly and Ala residues are present in the C2 and C1 inhibitor sequences, respectively. It is notable that Gln, found at the P 2 position in the C4 sequence, was not found at high frequency at all; thus, there are evidently other factors involved in the cleavage of the C4 protein versus the C2 substrate and C1 inhibitor sequences. The S 4 position favored Tyr, Ser, and Ala residues. It is interesting to note that serine is found in two physiological sequences, C2 and C1 inhibitor, whereas Gly is the residue found at this position in C4. Once again, the residue found at the C4 P 4 position is not among the most preferred (above 10), although in this case Gly was at least one of the better preferred residues among those found below a frequency of 10.
Studies by O'Brien et al. (14) indicated that interaction with the prime side substrate residues enhanced the affinity of C1s for its C2 and C4 substrates. From the data presented here, C1s displayed quite high specificity for leucine at the P 2 Ј position, but other prime side sites did not FIGURE 2. Frequency of occurrence of amino acids at P 4 -P 4 positions within phage from a fixed P 1 arginine library cleaved by C1s. These data represent the frequency of occurrence for each amino acid residue found at each of the substrate positions in 93 different phage peptides obtained from sequencing. A frequency greater than 5 is considered to be important, and therefore, the y axis is cut off at this value. individually affect specificity markedly. The frequency of occurrence of Leu at P 2 Ј ranked next after the Leu at P3 and Gly at P 2 , indicating that it does influence specificity to a significant extent. Leucine is found in both C1 inhibitor and C4 cleavage sequences at P 2 Ј. The Ile found at this position on C2 was a regularly found amino acid in the data analyzed here. The next highest preference in the prime positions was at the P 1 Ј position, with Ser, Ala, Leu, and Val residues occurring most frequently. Of the residues found in physiological cleavage sequences, only Ala, found at P 1 Ј in C4, was among the better residues. At the P 3 Ј position the most significant preferences were Arg, Leu, and Val, of which only the Leu is found in the C1 inhibitor sequence. At the P 4 Ј position, valine, found in the C1 inhibitor sequence, was the most frequently found residue. Isoleucine is found at this position in both the C4 and C2 sequences but was only found five times.
Analysis in the Context of the C1s
Crystal Structure-Analysis of the crystal structure of the C1s catalytic fragment, representing the CCP2-SP domains, has revealed that access to the non-prime binding sites in the vicinity of the active site in particular is restricted (12) . This was particularly evident at the S 2 position, where a major insertion loop is positioned over the active site and the Phe-511 residue in particular restricts access to this site. This provides a good explanation for the observed strong preference for small amino acids, such as Gly and Ala, at the P 2 position in substrates.
Because no inhibitor was docked into the active site in the crystal structure, further analysis of the subsites required the docking of a substrate/inhibitor sequence into the active site of the protease, performed essentially as described previously (18) . This allowed analysis of the S 3 site in particular, which our results show to be the most selective of all the sites aside from the S1 site. As shown in Fig. 3 , the S 3 pocket is hydrophobic but relatively shallow. The "walls" of the pocket consist of Phe-511, Tyr-595, Trp-640, and Pro-642, whereas Phe-597 acts as the "floor." Leu and Val residues, preferred at the P 3 position in substrates, therefore qualify for binding to this site from the point of view of being hydrophobic and also small enough to be accommodated by the shallow subsite. In contrast to the high degree of selectivity seen on the nonprime side, the prime side was found to have a relatively small degree of substrate selectivity. This is partly attributable to the prime binding sites being comparatively more open than the non-prime binding sites, as shown in Fig. 3 .
Significance of the Results-Having elucidated the most important determinants of specificity for the active site of the C1s protease, we asked whether the active site of C1s contained all of the information required to explain its apparently high selectivity for substrates in vivo. Certainly it appears that the C2 and C1 inhibitor cleavage sequences are a good fit with the active site of the enzyme. The interaction with residues at the cleavage site of C4 was less appropriate, particularly at the important P 2 position. This would seem to indicate that other sites on the substrate might interact with the enzyme to facilitate proper cleavage of the substrate, and indeed it has been shown that C4 interacts with the CCP domains of the C1s substrate to facilitate proper cleavage (19) .
We also considered whether the substrate selectivity of C1s gave any clues as to whether the enzyme was as selective for protein substrates as suggested by the limited range of substrates found mainly within the complement pathway. We constructed a model (available at pops.csse-.monash.edu.au) for its substrate selectivity within the Prediction of Protease Specificity (PoPS) (20) computer program and used this program to scan the human proteome for substrates that matched the selectivity criteria for C1s cleavage. It should be noted here that the active site specificity of the protease is just one factor contributing to the likelihood that a substrate will be cleaved at a particular position by a protease, albeit an important factor given that it always constitutes one of the premier zones of interaction with a substrate. Other factors include positioning by exosites, the structure of the substrate, and the location (e.g. intracellular versus extracellular) of substrates relative to the enzyme.
The model constructed in PoPS performed well in control analyses on the physiological substrates, particularly in the case of C2, where it correctly identified the correct cleavage site with a score of 47. For C1 inhibitor, an alternative cleavage site was predicted with a score of 43.5, whereas the authentic site scored next highest at 40. The "incorrect" predicted cleavage site for C1 inhibitor is sited at a position that would be predicted to be occluded behind the F ␣-helix of the serpin, and therefore, it appears that in this instance it is the structure of the inhibitor that dictates correct cleavage along with the specificity of the active site. For C4, the physiological cleavage site had the second highest score of 44, with the highest score being 49 for an alternative cleavage site. It appears that in this instance the correct cleavage might be dictated by positioning via the proposed exosite on C1s for the C4 substrate (19) , following which the active site selects the actual site of cleavage.
We then used the PoPS model to predict the cleavage sites for C1s in previously identified substrates outside of the complement pathway. It must be noted that the cleavage sites for C1s in these proteins have not yet been identified. The model predicted cleavage after Arg-83 in insulin-like growth factor-binding protein 5 (7) (score of 44.3) and after 
